SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-035182
Filing Date
2005-02-23
Accepted
2005-02-23 16:44:33
Documents
9
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR INVITROGEN CORPORATION d10k.htm 10-K 1580679
2 INDENTURE DATED AS OF DECEMBER 14,2004 dex410.htm EX-4.10 528177
3 INDENTURE DATED AS OF DECEMBER 14, 2004 dex411.htm EX-4.11 526425
4 LIST OF SUBSIDIARIES dex211.htm EX-21.1 15817
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2699
6 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 8773
7 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 8725
8 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex321.htm EX-32.1 4599
9 SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex322.htm EX-32.2 4622
  Complete submission text file 0001193125-05-035182.txt   2683186
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

IRS No.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-25317 | Film No.: 05634788
SIC: 2836 Biological Products, (No Diagnostic Substances)